Skip to main content
Sign In

Welcome to the website for the Department of Radiation Oncology at the University of Colorado Denver, affiliated with the University of Colorado Hospital.

Radiation Oncology Banner Image
 

David Raben, MD

Interests: Head and Neck Cancers, GU Cancers and Lung Cancer


Dr. David Raben is a board certified radiation oncologist at the University of Colorado and has recently been named a U.S. News Top Doctor. He received his undergraduate degree at Duke University (1981-1985) and his medical degree from Wake Forest University Health Sciences Center (1985-1990). Residency training in radiation oncology was conducted at the John Hopkins Hospital (1991-1994). He took his initial faculty position at the University of Alabama at Birmingham from 1994-1998 heading the GI tumor working group and receiving an American Cancer Society translational oncology grant to study brain tumors. Presently, he is a full professor in the only NCI-designated Comprehensive Cancer Center in the Rocky Mountain region at the University of Colorado Denver. Dr. Raben is nationally recognized regarding his work in targeted therapies and radiation, primarily in GI, head and neck cancer and lung cancer. He currently serves on the ASCO and ASTRO education and program planning committees. He also serves on the head and neck steering committee of the RTOG. Dr. Raben is a committee member of the GU section of the SWOG with extensive experience spanning over 14 years with low (LDR) and high dose rate (HDR) brachytherapy. The University of Colorado Radiation Oncology Dept. was the only site approved by the RTOG in Colorado to participate in the national phase II HDR brachytherapy trial (RTOG 0324). In addition, Dr Raben was the first radiation oncologist in the Rocky Mountain region to implement accelerated intensity modulated radiation to the prostate and pelvis, recently published in a respected peer-reviewed journal. His focus has also been on targeting critical signaling pathways driving cancer cells to enhance radiation therapy. This includes blocking the ability of cancer cells to repair and invade after treatment with radiation. He is an ad hoc reviewer for Cancer Research, Clinical Cancer Research, Head and Neck, Journal of Clinical Oncology and the International Journal of Radiation Oncology, Biology and Physics. He serves as the Director of the Radiological Sciences Core at the Cancer Center. Dr. Raben has contributed to 93 publications.
 
Click here to see Dr. Raben's publications